Lipella appoints Dr. Lori Birder to Board of Directors, effective June 17, 2023

LIPELLA PHARMACEUTICALS INC.

Dr. Birder appointed to the Board effective June 17, 2023, to serve until next annual meeting of stockholders.
She will serve on the Audit Committee and the Compensation Committee.
No arrangements, understandings, or transactions requiring disclosure under Item 404(a) exist with her appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Lori Birder

Director

LIPO · LIPELLA PHARMACEUTICALS INC.

Effective: 2023-06-17
Filed: June 23, 2023, 7:59 PM ET

Effective June 17, 2023, the board of directors (the “Board”) of Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), pursuant to its powers under the Company’s second amended and restated by-laws, appointed Dr. Lori Birder as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Lori Birder was appointed as Director at LIPELLA PHARMACEUTICALS INC..

Action: appointed
Role: Director

Exact text from the filing

Effective June 17, 2023, the board of directors (the “Board”) of Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), pursuant to its powers under the Company’s second amended and restated by-laws, appointed Dr. Lori Birder as a member of the Board.

View on SEC.gov

LIPELLA PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001753926-23-000846

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.